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Abstract—Bone tissue engineering is a rapidly developing area.
Engineering bone typically uses an artificial extracellular matrix
(scaffold), osteoblasts or cells that can become osteoblasts, and
regulating factors that promote cell attachment, differentiation,
and mineralized bone formation. Among them, highly porous scaf-
folds play a critical role in cell seeding, proliferation, and new
3D-tissue formation. A variety of biodegradable polymer mate-
rials and scaffolding fabrication techniques for bone tissue engi-
neering have been investigated over the past decade. This article
reviews the polymer materials, scaffold design, and fabrication
methods for bone tissue engineering. Advantages and limitations
of these materials and methods are analyzed. Various architectural
parameters of scaffolds important for bone tissue engineering (e.g.
porosity, pore size, interconnectivity, and pore-wall microstruc-
tures) are discussed. Surface modification of scaffolds is also dis-
cussed based on the significant effect of surface chemistry on cells
adhesion and function.
Keywords—Bone, Tissue engineering, Biodegradable, Polymer
materials, Scaffolds.
INTRODUCTION
Bone tissue engineering offers a promising new approach
for bone repair.50,67,96 Compared to traditional autograft and
allograft procedures, bone tissue engineering techniques
based on autogenous cell/tissue transplantation would elim-
inate problems of donor scarcity, supply limitation, and
pathogen transfer and immune rejection.15,61 Therefore, it
has become a rapidly expanding research area since the
emergence of the concept of tissue engineering.3,19,29,60
Engineering bone typically uses an artificial extracellu-
lar matrix (or scaffold), osteoblasts or cells that can become
osteoblasts, and regulating factors that promote cell recruit-
ment, growth differentiation and mineralized bone tissue
formation. Among them, highly porous scaffolds play a
critical role in cell seeding, proliferation and new tissue
formation in three dimensions (3D).63,64 The scaffold is
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a 3D substrate for cells, and serves as a template for tis-
sue regeneration. Ideal scaffolds should be biocompatible,
biodegradable, and promote cellular interactions and tissue
development, and possess proper mechanical and physical
properties.10,39,105
A variety of materials have been used for replacement
and repair of damaged or traumatized bone tissues.34,49,57,92
These materials include metals, ceramics, polymers (natu-
ral and synthetic) and their combinations. Metals and ce-
ramics have two major disadvantages for tissue engineering
applications: they are lack of degradability in a biological
environment, and their processability is very limited.68 In
contrast, polymers have great design flexibility because the
composition and structure can be tailored to the specific
needs. They are therefore attractive candidates. Biodegrad-
ability can be imparted into polymers through molecular
design. Some polymers contain chemical bonds that un-
dergo hydrolysis upon exposure to the body’s aqueous en-
vironment, and some others can degrade by cellular or en-
zymatic pathways. For these reasons, polymeric materials
have received considerable attention and are widely stud-
ied for bone tissue engineering applications.13 This review
will focus on the selection of polymeric materials, scaffold
design, and fabrication techniques. Surface modification of
scaffolds is also discussed considering the significant effect
of surface chemistry on cells adhesion and function. Many
other factors such as cell sources, regulating molecules and
their delivery, mechanical stimulation, bioreactor design,n
vitro andin vivocultivation conditions, animal models, and
clinical considerations are also critically important for suc-
cessfully engineering bone and other mineralized tissues.
However they are beyond the scope of this paper and will
not be covered here.
POLYMERIC MATERIALS
The scaffolds for bone tissue engineering should be fab-
ricated from a biocompatible polymer, which does not have
the potential to elicit an immunological or foreign body
reaction. The chosen polymer can degrade at a controlled
rate in concert with tissue regeneration. The degradation
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products should not be toxic and must be easily excreted
by metabolic pathways. Many types of polymeric materials
have been used for bone tissue engineering.4,34,81 They can
be simply categorized as naturally derived materials [e.g.
collagen and fibrin) and synthetic polymers (e.g. poly(lactic
acid) (PLA), poly(glycolic acid) (PGA), and their copoly-
mers PLGA]. Naturally derived materials have the poten-
tial advantage of biological recognition that may positively
support cell adhesion and function. However, they may ex-
hibit immunogenicity and contains pathogenic impurities.
There is also less control over their mechanical properties,
biodegradability, and batch-to-batch consistency. Many of
them are also limited in supply and can therefore be costly.
An advantage of synthetic polymers is reproducible large-
scale production with controlled properties of strength,
degradation rate and microstructure. Therefore, synthetic
biodegradable polymers have been widely used as vehicles
for cell transplantation and scaffolds for tissue engineering.
Collagen is a fibrous protein, and is a main component of
extracellular matrix of mammalian tissues including bone,
cartilage, tendon, ligament, skin and so on.6,27,43,86,98 About
25 types of collagen differing in their chemical compo-
sition and molecular structure have been identified so far
while type I collagen is known to be the most abundant one
of all.46 Mizuno et al. utilized type I collagen as the ma-
trix of bone marrow stromal cells and found bone marrow
stromal cells could differentiate into osteoblasts on type I
collagen matrixin vivo, but type II, III, and V collagen
did not possess this property.74 Their results implied that
type I collagen matrix offers a suitable environment for the
induction of osteoblastic differentiationi vitro and osteo-
genesisin vivo. Caplan’s group investigated the possibility
of using hyaluronic acid-based polymers as cell carriers for
tissue-engineered repair of bone and cartilage.90 Their re-
sults indicated that the hyaluronic acid-based delivery ve-
hicles are superior to porous calcium phosphate ceramic
with respect to the amount of cells loaded per unit volume
of implant. As mentioned above, there are several concerns
over the use of natural polymers as scaffolds for bone tissue
engineering. These include their weak mechanical strength
to give sufficient structural support and protection for the
seeded osteoblasts, and the risks of pathogen transmission
and immunorejection associated with natural materials from
animal and cadaver sources.
Poly(α-hydroxy acids), including PGA, PLA, and
their copolymer PLGA, are the most popular and
widely used synthetic polymeric materials in bone tissue
engineering.24,36,42,44,55,65,79 These polymers, having a long
history of use as degradable surgical sutures, have gained
FDA approval for certain human use and are reasonably
biocompatible. The ester bonds in these polymers are hy-
drolytically labile, and these polymers degrade by nonenzy-
matic hydrolysis. The degradation products of PGA, PLA
and PLGA are nontoxic, natural metabolites, and are even-
tually eliminated from the body in the form of carbon diox-
ide and water. The degradation rates of these polymers
can be tailored to satisfy the requirements from several
weeks to several years by altering the chemical composi-
tion (e.g. the LA/GA ratio in the PLGA copolymers), crys-
tallinity, molecular-weight, and molecular weight distribu-
tion. Although these polymers have already been widely
used in bone tissue engineering research, there are ongo-
ing research efforts in improving the functionality of these
polymers to further expand their applications. Other poly-
mers have also been investigated for bone regeneration such
as polyanhydrides,32,41,95 polycarbonates,16,23 polyphos-
phazene,52 polyfumarates,80,107 and poly(butylenes tereph-
thalate)/poly(ethylene oxide).20
Synthetic degradable hydrogels are emerged as a way
to deliver cells and serve as injectable scaffolds for tissue
engineering. PEG-based hydrogel scaffolds have been de-
veloped for bone regeneration by several groups.12,31,59,73
The nonadhesive hydrogel was modified with adhesive
RGD peptide to facilitate cell adhesion and spreading. In-
creased osteoblast attachment and spreading were observed
at high RGD concentrations.12 Poly(propylene fumarate-
co-ethylene glycol) hydrogels with a covalently linked RGD
peptides were also developed.8 The RGD concentration was
found to regulate osteoblast migration.8 Poly(aldehyde gu-
luronate) hydrogel was also used as a hydrogel for bone
regeneration.53 In addition to collagen, other naturally de-
rived polymers such as alginate and their modifications were
also used as hydrogels for bone tissue engineering.2,45,48,88
These hydrogels can be injected into the body in a min-
imally invasive manner for cell and protein delivery.21,85
However, a disadvantage of hydrogels for bone tissue engi-
neering application is their low mechanical strength, posing
difficulties in handling.
Although various polymeric materials are available and
have been investigated for bone tissue engineering, no sin-
gle biodegradable polymer can meet all the requirements
for bone tissue engineering scaffolds. Each polymer ma-
terial has its own characteristic advantages and disadvan-
tages. On the other hand, composite materials often show
an excellent balance between strength and toughness and
usually improved characteristics compared to their individ-
ual components. As a matter of fact, natural bone matrix
is an organic/inorganic composite material of collagen and
apatites. From this point of view, composite materials are
better choices as bone tissue engineering scaffolds.35,110,111
It is well established that hydroxyapatite (HAP) mimics the
natural bone mineral and has been found to possess good
mechanical and osteoconductive properties.1,82,99 Marra
et al. incorporated HAP granules into poly(caprolactone)
and PLGA blends and revealed the formation of collagen
500µm into the scaffold.69 Mikos’s group mixed HAP short
fibers as a reinforcing material to create porous poly(α-
hydroxy ester)/HAP composites.94 The processing tech-
nique involves solvent casting and compression molding
followed by particulate leaching. The compressive yield
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strength of low porosity composite foams increased with
increasing HAP fiber content. However, high porosity com-
posite foams, which are suitable for cell seeding, were not
reinforced by the introduction of increasing quantities of
HAP short fibers. Laurencinet al.blended PLGA and HAP
in attempt to improve mechanical properties as well as in-
crease the osteoconductivity of PLGA scaffolds.5,51 In a
21-day osteoblast culture on the PLGA/HAP composite ma-
trix, the cell attachment, function, and mineral formation
showed some promising features of the HAP-containing
matrix. However, the porosity of the scaffold was quite low,
which might not be ideal for long-term cell survival, pro-
liferation, and tissue formation due to mass transport limi-
tations. Our group developed highly porous biodegradable
polymer/apatite composite scaffolds through a thermally
induced phase separation technique.110 Porosity as high
as 95% was achieved. The mechanical properties of the
composite scaffolds were significantly improved over the
pure polymer scaffolds. The compressive modulus reached
the same range as trabecular bone. Thein vitro experi-
ments confirmed that the osteoblast survival and growth
were significantly enhanced in the PLLA/HAP composite
scaffolds compared to the plain PLLA scaffolds.67 Bone-
specific markers, such as osteocalcin and bone sialopro-
tein, were expressed more abundantly in the PLLA/HAP
composite scaffolds than in the PLLA scaffolds. Further-
more, the new bone tissue formation was significantly en-
hanced and was quite uniformly distributed throughout the
PLLA/HAP composite scaffolds in contrast to only sur-
face layer growth in plain PLLA scaffolds. The results from
these groups consistently suggest that the strategy of using
composite scaffolds of biodegradable polymers and bone
mineral-like inorganic compounds is a viable approach in
bone tissue engineering.
SCAFFOLD DESIGN AND FABRICATION
Several requirements should be considered in the design
of 3D scaffolds for bone tissue engineering.28,40,105 First
of all, an ideal bone scaffold should have sufficient poros-
ity to accommodate osteoblasts or osteoprogenitor cells, to
support cell proliferation and differentiation, and to enhance
bone tissue formation. High porosity (such as≥90%) is im-
portant for scaffolds for any tissue engineering applications,
including bone.67,97 High interconnectivities between pores
are also desirable for uniform cell seeding and distribution,
the diffusion of nutrients to and metabolites out from the
cell/scaffold constructs. The scaffold should have adequate
mechanical stability to provide a suitable environment for
new bone tissue formation. The scaffold degradation rate
must be tuned to match the rate of new bone tissue regen-
eration in order to maintain the structural integrity and to
provide scaffolding cues for tissue formation. Furthermore,
the scaffold should have suitable surface chemistry for bone
cells adhesion and function.
A variety of processing technologies have been devel-
oped to fabricate porous 3D polymeric scaffolds for bone
regeneration. These techniques mainly include solvent cast-
ing and particulate leaching, gas foaming, emulsion freeze-
drying, electrospinning, rapid prototyping, and thermally
induced phase separation.
Solvent-Casting and Particulate Leaching Technique
Solvent casting and particulate leaching is a simple and
most commonly used method for fabricating scaffolds for
tissue engineering.64,72 This method involves mixing water-
soluble salt (e.g. sodium chloride, sodium citrate) particles
into a biodegradable polymer solution. The mixture is then
cast into the mold of the desired shape. After the solvent is
removed by evaporation or lyophilization, the salt particles
are leached out to obtain a porous structure. This method
has advantages of simple operation, adequate control of
pore size and porosity by salt/polymer ratio and particle
size of the added salt. Mikoset al. used this method to
fabricate biodegradable polymer scaffolds to engineer tra-
becular bone.72,93 However, the pore shape is limited to
the cubic crystal shape of the salt. The difficulty of remov-
ing soluble particles from the interior of a polymer matrix
makes it hard to fabricate very thick 3D scaffolds.76 In fact,
most of the porous materials prepared by solvent casting and
particulate leaching method are limited to thickness rang-
ing from 0.5 to 2 mm.56 In addition, their limited interpore
connectivity is disadvantageous for uniform cell seeding
and tissue growth. Sikavitsaset al.broken PLGA/salt com-
posite materials into small pieces and compression molded
them into thicker samples and then dissolved the salt to gen-
erate needed scaffolds for bone tissue engineering studies
in bioreactors. Nonetheless, cell growth and mineralization
were limited to the outside of the scaffolds, which was at-
tributed to limited internal nutrient transport conditions by
the investigators.89
Our group developed a method to create biodegrad-
able polymer scaffolds with spherical pore shape and well-
controlled interpore connectivity.62 Paraffin spheres are
chosen as pore-generating materials. The created new scaf-
folding has a homogeneous foam skeleton (Fig. 1). The con-
trol of porosity and the pore size can be achieved by chang-
ing the concentration of the polymer solution, the number
of the casting steps, and the size of the paraffin spheres. The
main advantage of this method is that it can ensure the cre-
ation of a totally interconnected pore network in the polymer
scaffold, which is critical to uniform cell seeding, tissue in-
growth, and regeneration. In addition, the paraffin sphere
assembly can be dissolved in some organic solvents but not
water. Therefore, certain water-soluble polymers can be in-
volved in fabricating such scaffolds. However, what is the
ideal pore size and interpore connectivity of such scaffolds
for bone tissue engineering is yet to be investigated.
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FIGURE 1. SEM micrographs of poly( α-hydroxy acids) scaf-
folds. (a) PLLA foams prepared with paraffin spheres with a
size range of 250–350 µm (×250). (b) PLGA foams prepared
with paraffin spheres with a size range of 420–500 µm (×50).
(From Ma and Choi, 62 copyright 2000 by Mary Ann Liebert, Inc.
Reprinted with permission.)
Gas-Foaming Process
Gas foaming process can be used to fabricate highly
porous polymer foams without the use of organic
solvents.18,33,75 In this approach, carbon dioxide (CO2) is
usually used as an agent for the formation of polymer foam.
Solid polymer disks are exposed to high pressure CO2 to
allow saturation of CO2 in the polymer. Thermodynamic in-
stability is then created by rapidly releasing CO2 gas from
the polymer system, followed by the nucleation and growth
of gas bubbles in the material. Polymer sponges with a pore
size of 100µm and a porosity up to 93% can be fabricated
using this technique. The disadvantage of this method is that
it yields mostly a nonporous surface and closed-pore struc-
ture, with only 10–30% of interconnected pores.33,75 The
porosity and interpore connectivity can be significantly im-
proved by combining particulate leaching technique with
the gas-foaming process although completely eliminating
closed pores remains challenging.33
Emulsion Freeze Drying
Emulsion freeze-drying technique was used for the fab-
rication of highly porous PLGA scaffolds.101,102 The pro-
cessing method consists of creating an emulsion by homog-
enization of a polymer solution (in an organic solvent) and
water mixture, rapidly cooling the emulsion to lock in the
liquid state structure, and removing the solvent and water
by freeze-drying. Scaffolds with porosity greater than 90%
and a pore size ranging from 20 to 200µm can be fabricated
with this method.101 One disadvantage of this technique is
the closed pore structure in the resulting matrix.76
Electrospinning Technique
Electrospinning is a fabrication process that uses an elec-
tric field to control the formation and deposition of polymer
fibers onto a target substrate.9,38,70,83,108 In electrospinning,
a polymer solution or melt is injected with an electrical po-
tential to create a charge imbalance. At a critical voltage,
the charge imbalance begins to overcome the surface tension
of the polymer solution to form an electrically charged jet.
The jet within the electric field is directed toward the ground
target, during which time the solvent evaporates and fibers
are formed. This electrospinning technique can fabricate fi-
brous polymer scaffolds with fiber diameters ranging from
several microns down to several hundred nanometers.54 The
3D scaffold shapes other than sheets or cylinders have not
been demonstrated using this technique.
Rapid-Prototyping Techniques
Rapid prototyping is a technology based on the ad-
vanced development of computer science and manufactur-
ing industry.106 The main advantage of these techniques is
their ability to produce complex products rapidly from a
computer-aided design (CAD) model. One of these rapid
prototyping techniques, called 3D printing, was first devel-
oped at the Massachusetts Institute of Technology and has
been used to process biodegradable polymer scaffolds for
tissue engineering applications.26,84 This process generates
components by ink-jet printing a binder on to sequential
powder layers. The operation parameters such as the speed,
flow rate, and drop position can be computer controlled to
produce complex 3D polymer scaffolds. Biological agents,
such as growth factors, can also be incorporated into the
scaffolds in the printing process. However, the limitation of
this method is that the resolution is determined by the jet
size, which makes it difficult to design and fabricate scaf-
folds with fine microstructures. The porosity of the scaffold
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fabricated with this method is low, and the mechanical prop-
erties of the scaffolds have to be significantly improved.108
Thermally Induced Phase Separation
The controlled thermally induced phase separation pro-
cess was first used for the preparation of porous polymer
membranes. This technique was recently utilized to fab-
ricate biodegradable 3D polymer scaffolds.109 In this ap-
proach, the polymer is first dissolved in a solvent at a high
temperature, liquid–liquid or solid–liquid phase separation
is induced by lowering the solution temperature. Subse-
quent removal of the solidified solvent-rich phase by sub-
limation leaves a porous polymer scaffold.58,76,87,109 The
pore morphology of the scaffolds varies depending on the
polymer, solvent, concentration of the polymer solution and
phase separation temperature. One advantage of this method
is that the fabricated scaffolds often have good mechanical
properties. For example, a PLLA scaffold fabricated using
a solid–liquid phase separation technique has a modulus
approximately 20 times higher than that of the scaffold fab-
ricated using the well-documented salt-leaching technique
from the same polymer and with the same porosity.67 How-
ever, this method usually generate scaffolds with a pore
size of 10–100µm, which may not be ideal for osteoblas-
tic cell seeding and bone tissue growth. Using a coarsening
process in the later stage of thermally induced phase sepa-
ration, macroporous scaffolds with a pore diameter greater
than 100µm can be generated.76,100
By using a solid–liquid phase separation technique, our
group fabricated biodegradable polymeric scaffolds with a
parallel array of microtubules (Fig. 2).65 Phase separation
was induced using a uniaxial temperature gradient to obtain
the oriented microtubular scaffolds. The porosity, diameter
of the microtubules, the tubular morphology and their ori-
entation can be controlled by fabrication parameters such
as polymer concentration, solvent type, and temperature
gradient. The mechanical properties of these scaffolds are
also anisotropic, similar to oriented tissues. The new micro-
tubular architecture may serve as superior scaffolds for the
engineering of a variety of tissues with fibrillar and tubular
architectures.
Collagen is one of the main extracellular matrix compo-
nents of bone tissue, and its nano-fibrous architecture has
long been noticed to play a role in cell adhesion, growth and
differentiated function in tissue cultures.22,30,47,91 To mimic
the nanofibrous architecture, our group developed a novel
liquid-liquid phase separation technique to create a 3D
interconnected fibrous network with a fiber diameter rang-
ing from 50 to 500 nm (Fig. 3).66 Typically, the nanoscale
fibrous matrices were fabricated with five steps: polymer
dissolution, phase separation and gelation, solvent extrac-
tion, freezing, and then freeze-drying under vacuum. The
fiber network formation depends on the gelling temperature
and the solvent of the polymer solution. This nanofibrous
FIGURE 2. SEM micrographs of porous PLLA scaffolds
prepared in benzene or dioxane solutions using a phase-
separation technique. (a) 2.5% (wt/v) PLLA/benzene, uniax-
ial temperature gradient, longitudinal section. (b) 5% (wt/v)
PLLA/dioxane, uniaxial temperaure gradient, longtitudinal sec-
tion. (From Ma and Zhang, 65 copyright 2001 by John Wiley &
Sons, Inc. Reprinted with permission.)
matrix has a much higher surface-to-volume ratio than
those of fibrous nonwoven fabrics fabricated with the textile
technology or foams fabricated with other techniques.
When combined with the porogen leaching technique,
synthetic polymer scaffolds are created with architectural
features at several levels, including the anatomical shape
(defined by a mold), macroporous elements (100µm
to millimeters), interfiber distance (microns), and the
diameter of the fibers (50 to 500 nm).103,112 These synthetic
analogues of natural extracellular matrices combine the
advantages of the synthetic biodegradable polymers and the
nanoscale architecture similar to the natural extracellular
matrix. They were found to selectively enhance protein
adsorption and promote osteoblastic cell adhesion.103
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FIGURE 3. SEM micrographs of a PLLA fibrous matrix prepared
from 2.5% (wt/v) PLLA/THF solution at a gelation temperature
of 8◦C: (a) ×50; (b) ×20K. (From Ma and Zhang, 66 copyright
1999 by John Wiley & Sons, Inc. Reprinted with permission.)
Surface Modification
In tissue engineering, it is important to consider the
interactions of cells with the scaffolding materials. The
nature of the surface can directly affect cellular response,
ultimately influencing the rate and quality of new tissue
formation. Surface chemistry as well as surface topography
determine whether protein molecules can adsorb and how
cells attach and align themselves.11 Although a variety of
synthetic biodegradable polymers have been used as tissue
engineering scaffolding materials, one disadvantage of
these scaffolds is their lack of biological recognition on the
material surface. Hydrophobic polymers do not provide
the ideal environment for cell-material interactions.71
Therefore, surface modification of polymeric scaffolds is
an active research area.77,104
Gao et al. described a procedure for surface hydroly-
sis of PGA scaffold under strong alkaline condition to in-
crease cell seeding density and improve biomaterial-cell
interactions.25 Hydrolysis of ester bonds on the surface
of PGA fibers changes the surface properties and results
in higher seeding density and more spreading of cells as
compared to unmodified PGA scaffolds. Caiet al. grafted
chitosan on to poly(D,L-lactic acid) (PDLLA) by a cou-
pling reaction on partially hydrolyzed PDLLA surface.
The adhesion and proliferation of osteoblasts on modi-
fied PDLLA films were improved compared to the control
PDLLA films.14 The limitation of this method is that it is
technique sensitive and hydrolysis also alters the surface
morphology and bulk mechanical properties.
Langer’s group synthesized poly(L-lactic acid-co-L-
lysine) and chemically attached RGD peptide to the lysine
residue of the copolymer.7,17 This approach combines the
advantage of both natural and synthetic materials. The pep-
tide content of the copolymer and their resulting chemical
and physical characteristics could be varied in a controlled
fashion by changing the molar ratio of the peptide to lysine
units. These poly(α-hydroxy acid)-based copolymers can
be further modified by chemical attachment of a variety of
biologically active molecules to meet the specific needs of
biomedical and tissue engineering applications.
Plasma exposure is an effective procedure for sur-
face etching. Nitschkeet al. utilized low pressure am-
monia plasma treatment for the modification of poly(3-
hydroxybutyrate) (PHB) thin films.78 The introduction of
amine function was used for subsequent protein immobi-
lization. The plasma treatment of PHB induced a durable
conversion from a hydrophobic into a hydrophilic surface
without significantly altering the morphology. Hollinger’s
group proposed a surface modification method using NH3
plasma treatment, followed by the attachment of poly(L-
lysine) and RGD peptide.37 The surface-modified polymer
films enhanced osteoprogenitor cell attachment. Because of
the limited plasma penetration, this method can only be used
for two-dimensional (2D) films or very thin 3D structures.
As discussed earlier, most of the surface modification
work this far has been focusing on 2D film surfaces or
very thin 3D constructs. True 3D scaffolding surface mod-
ification is still a challenge. This is an area that has sig-
nificant needs and potential for growth. Our group devel-
oped a biomimetic process that allows thein situ apatite
formation on the internal surfaces of the pore walls of
polymer scaffolds using simulated body fluids (SBF).111
A large number of microparticles with nano-featured flake-
and needle-shaped bone-like apatites was grown on the in-
ternal surfaces of the porous polymer scaffolds (Fig. 4).
The particle size and their coverage of pore surfaces
can be controlled by the incubation conditions such as
SBF concentration, incubation time, pH value, pretreat-
ment using aqueous solution and so forth to achieve a
desired surface modification pattern. In addition to the
aimed surface chemical modification for improved osteo-
conductivity, the mechanical properties of the scaffolds
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FIGURE 4. SEM micrographs of a PLLA scaffolds incubated in
a simulated body fluid for 30 days: original magnifications (a)
×100, (b) ×500, (c) ×2000, and (d) ×10,000. (From Zhang and
Ma,111 copyright 1999 by John Wiley & Sons, Inc. Reprinted
with permission.)
were also significantly improved over the plain polymer
scaffolds.111
PERSPECTIVES
The requirements of scaffolds for bone tissue engineer-
ing are complex. A variety of characteristic parameters,
such as degradation rate, mechanical strength, porosity, pore
size, pore microstructures, surface chemistry, and topogra-
phy, should be carefully considered and controlled for the
design and fabrication of scaffolds to meet the needs of a
specific tissue engineering application. Although the ideal
matrix materials and 3D scaffolds for bone tissue engineer-
ing have yet to be developed, much progress has been made
during the last 10 years. The development, fabrication, and
analysis of novel biodegradable polymeric biomaterials and
scaffolds will still constitute a centerpiece of the research
efforts in the field of bone tissue engineering. Using poly-
mer scaffolding to controllably manipulate osteoblastic cell
function is still in its infancy and expansion of this field will
likely enable development of new therapies and technolo-
gies for bone tissue repair and regeneration.
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